HealthEquity Accelerates Profitability and Raises FY27 Outlook on HSA Surge and AI‑Driven Efficiency

The first‑quarter results underscored the power of HealthEquity’s platform strategy – a blend of account growth, asset accumulation and digital engagement that is beginning to behave like a financial operating system for health care.  “Execution of our strategy alongside accelerating growth is reinforcing confidence in the long‑term outlook,” said President and CEO Scott Cutler, highlighting an adjusted EBITDA margin that jumped to **46%**, up from **42%** a year earlier.

Revenue rose **7% YoY** to a record $297 million, with service revenue climbing 3% to $123 million and custodial revenue surging 11% to $174 million. The company posted GAAP net income of $69.4 million ($0.82 per diluted share) and non‑GAAP net income of $105 million ($1.24 per share). Adjusted EBITDA reached $165 million, a **17%** year‑over‑year increase.

Key to the top‑line beat was a 19% rise in total HSA assets and a 15% jump in newly opened HSAs – **172,000** new accounts added in the quarter. HealthEquity’s HSA cash yield hit **3.84%**, boosted by a one‑time breakage fee; excluding that, the yield would have been 3.78%, still above the industry average. The firm noted that its growth outpaced Devenir’s reported market expansion of 6% for calendar‑year 2025.

Beyond raw account numbers, HealthEquity is extracting more value per member. “Members are engaging more deeply as they save, spend and invest,” Cutler said, pointing to an 18% rise in HSA investors and a **38%** jump in invested assets held within HSAs. Mobile monthly active usage exploded **90% YoY**, and two‑thirds of marketplace transactions now flow through the app.

The “Mark” marketplace – a curated health‑related product suite – moved beyond its proof‑of‑concept phase. More than 10,000 members are using Mark, with new offerings in diagnostics, men’s health and metabolic programs. While the company did not break out marketplace revenue, Cutler emphasized that these services carry high margins because they incur little acquisition cost and negligible service expense.

Efficiency gains were a recurring theme. AI‑driven tools cut manual email handling by **25%**, trimmed card‑service contacts by over 50,000, and reduced fraud reimbursements to members from $3.2 million a year ago to just $300 thousand this quarter – a near‑90% decline. “We are still at the beginning of the journey,” Cutler noted, but the automation of claims and card servicing has already slashed processing times by up to 50%.

Capital allocation reflected confidence in cash generation. The balance sheet showed **$265 million** in cash, $98 million of operating cash flow, and a net debt position of **$943 million**. Management accelerated its share‑repurchase program with $123 million bought back in the quarter and announced an additional **$1 billion** authorization for future repurchases.

Guidance was upgraded across the board. HealthEquity now expects fiscal 2027 revenue between **$1.41 billion and $1.42 billion**, GAAP net income of **$242 million‑$248 million** ($2.88‑$2.95 per share), non‑GAAP net income of **$392 million‑$398 million** ($4.66‑$4.73 per share) and adjusted EBITDA of **$625 million‑$633 million**. The outlook assumes the HSA cash yield will average **3.85%** for FY27, aided by forward treasury contracts that lock in 5‑year rates at roughly 3.9%.

Analysts probed the sustainability of margin improvements and the scalability of Mark. While management refrained from quantifying marketplace contribution, they stressed that “the incremental margin on a marketplace transaction is very high” because it bypasses traditional acquisition costs. On AI spending, CFO James Lucania explained that current token‑based compute costs are absorbed within the technology budget, but future savings will flow back to the bottom line as automation expands.

The stock reacted positively, climbing **4.57%** in after‑hours trading and up **3.39%** for the week, despite a year‑to‑date decline of 1.19%. The price rally reflects investor confidence that HealthEquity’s blend of account growth, digital engagement and cost discipline will translate into durable earnings expansion.

Overall, HealthEquity is turning its platform ambition into measurable financial performance, leveraging HSA market tailwinds, AI‑enabled efficiencies and a nascent but high‑margin marketplace to deliver stronger profitability and an upgraded outlook.